State Street Corp Has $395.51 Million Stock Position in DaVita Inc. (NYSE:DVA)

State Street Corp lowered its stake in DaVita Inc. (NYSE:DVA - Free Report) by 5.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,412,662 shares of the company's stock after selling 130,469 shares during the quarter. State Street Corp owned about 2.94% of DaVita worth $395,508,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quantinno Capital Management LP raised its stake in shares of DaVita by 11.8% in the 3rd quarter. Quantinno Capital Management LP now owns 17,394 shares of the company's stock worth $2,851,000 after buying an additional 1,840 shares in the last quarter. Quarry LP bought a new position in shares of DaVita during the 3rd quarter valued at about $60,000. Royal London Asset Management Ltd. lifted its stake in DaVita by 1.9% during the third quarter. Royal London Asset Management Ltd. now owns 20,684 shares of the company's stock valued at $3,391,000 after purchasing an additional 379 shares during the last quarter. Redwood Investment Management LLC lifted its position in shares of DaVita by 4.0% during the 3rd quarter. Redwood Investment Management LLC now owns 10,360 shares of the company's stock valued at $1,690,000 after acquiring an additional 402 shares during the last quarter. Finally, Integrated Wealth Concepts LLC boosted its position in shares of DaVita by 81.5% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 9,915 shares of the company's stock valued at $1,625,000 after purchasing an additional 4,452 shares during the period. Institutional investors own 90.12% of the company's stock.

DaVita Stock Down 2.7 %

DaVita stock traded down $4.25 during trading hours on Tuesday, hitting $153.81. The company had a trading volume of 788,716 shares, compared to its average volume of 813,406. The firm's fifty day moving average is $158.46 and its 200-day moving average is $150.52. The firm has a market capitalization of $12.61 billion, a P/E ratio of 17.05, a price-to-earnings-growth ratio of 0.90 and a beta of 0.90. DaVita Inc. has a fifty-two week low of $103.40 and a fifty-two week high of $169.51. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion for the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the prior year, the business posted $2.85 earnings per share. DaVita's revenue was up 4.6% on a year-over-year basis. On average, research analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current year.

Wall Street Analyst Weigh In

DVA has been the subject of a number of analyst reports. Truist Financial upped their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research note on Monday, October 7th. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $161.80.

Insider Activity at DaVita

In related news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction on Monday, September 16th. The shares were sold at an average price of $165.05, for a total value of $8,252,500.00. Following the completion of the sale, the chief executive officer now owns 837,835 shares of the company's stock, valued at approximately $138,284,666.75. The trade was a 5.63 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is currently owned by company insiders.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.